274 related articles for article (PubMed ID: 31041875)
1. Bortezomib and metformin opposingly regulate the expression of hypoxia-inducible factor alpha and the consequent development of chemotherapy-induced painful peripheral neuropathy.
Ludman T; Melemedjian OK
Mol Pain; 2019; 15():1744806919850043. PubMed ID: 31041875
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib-induced aerobic glycolysis contributes to chemotherapy-induced painful peripheral neuropathy.
Ludman T; Melemedjian OK
Mol Pain; 2019; 15():1744806919837429. PubMed ID: 30810076
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib induces neuropathic pain through protein kinase C-mediated activation of presynaptic NMDA receptors in the spinal cord.
Xie JD; Chen SR; Chen H; Pan HL
Neuropharmacology; 2017 Sep; 123():477-487. PubMed ID: 28663117
[TBL] [Abstract][Full Text] [Related]
4. Blocking TRPA1 and TNF-α Signal Improves Bortezomib-Induced Neuropathic Pain.
Li C; Deng T; Shang Z; Wang D; Xiao Y
Cell Physiol Biochem; 2018; 51(5):2098-2110. PubMed ID: 30522101
[TBL] [Abstract][Full Text] [Related]
5. The Actions and Mechanisms of P2X7R and p38 MAPK Activation in Mediating Bortezomib-Induced Neuropathic Pain.
Guo Y; Xu X; Huang J; Wang Z; Li Z; Liu Z
Biomed Res Int; 2020; 2020():8143754. PubMed ID: 32733956
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse.
Carozzi VA; Renn CL; Bardini M; Fazio G; Chiorazzi A; Meregalli C; Oggioni N; Shanks K; Quartu M; Serra MP; Sala B; Cavaletti G; Dorsey SG
PLoS One; 2013; 8(9):e72995. PubMed ID: 24069168
[TBL] [Abstract][Full Text] [Related]
7. Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
Zheng H; Xiao WH; Bennett GJ
Exp Neurol; 2012 Dec; 238(2):225-34. PubMed ID: 22947198
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PAR2 and TRPA1 signals alleviates neuropathic pain evoked by chemotherapeutic bortezomib.
Wang Q; Wang J; Gao D; Li J
J Biol Regul Homeost Agents; 2017; 31(4):977-983. PubMed ID: 29254302
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of TRPC6 Mediated by PAX6 Hypomethylation Is Involved in the Mechanical Allodynia Induced by Chemotherapeutics in Dorsal Root Ganglion.
Zhang XZ; Luo DX; Bai XH; Ding HH; Liu M; Deng J; Mai JW; Yang YL; Zhang SB; Ruan XC; Zhang XQ; Xin WJ; Xu T
Int J Neuropsychopharmacol; 2020 Apr; 23(4):257-267. PubMed ID: 32124922
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
Carozzi VA; Canta A; Chiorazzi A
Neurosci Lett; 2015 Jun; 596():90-107. PubMed ID: 25459280
[TBL] [Abstract][Full Text] [Related]
11. TNF-α-mediated JNK activation in the dorsal root ganglion neurons contributes to Bortezomib-induced peripheral neuropathy.
Zhang J; Su YM; Li D; Cui Y; Huang ZZ; Wei JY; Xue Z; Pang RP; Liu XG; Xin WJ
Brain Behav Immun; 2014 May; 38():185-91. PubMed ID: 24530998
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of NLRP3 via STAT3-dependent histone acetylation contributes to painful neuropathy induced by bortezomib.
Liu CC; Huang ZX; Li X; Shen KF; Liu M; Ouyang HD; Zhang SB; Ruan YT; Zhang XL; Wu SL; Xin WJ; Ma C
Exp Neurol; 2018 Apr; 302():104-111. PubMed ID: 29339053
[TBL] [Abstract][Full Text] [Related]
13. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
[TBL] [Abstract][Full Text] [Related]
14. P2X3-mediated peripheral sensitization of neuropathic pain in resiniferatoxin-induced neuropathy.
Hsieh YL; Chiang H; Lue JH; Hsieh ST
Exp Neurol; 2012 May; 235(1):316-25. PubMed ID: 22391132
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of CCL2 via ATF3/c-Jun interaction mediated the Bortezomib-induced peripheral neuropathy.
Liu C; Luan S; OuYang H; Huang Z; Wu S; Ma C; Wei J; Xin W
Brain Behav Immun; 2016 Mar; 53():96-104. PubMed ID: 26554515
[TBL] [Abstract][Full Text] [Related]
16. Critical role of Ca
Tomita S; Sekiguchi F; Deguchi T; Miyazaki T; Ikeda Y; Tsubota M; Yoshida S; Nguyen HD; Okada T; Toyooka N; Kawabata A
Toxicology; 2019 Feb; 413():33-39. PubMed ID: 30552955
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.
Makker PG; Duffy SS; Lees JG; Perera CJ; Tonkin RS; Butovsky O; Park SB; Goldstein D; Moalem-Taylor G
PLoS One; 2017; 12(1):e0170814. PubMed ID: 28125674
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen suppresses paclitaxel-, vincristine-, and bortezomib-induced neuropathy via inhibition of the protein kinase C/extracellular signal-regulated kinase pathway.
Tsubaki M; Takeda T; Matsumoto M; Kato N; Yasuhara S; Koumoto YI; Imano M; Satou T; Nishida S
Tumour Biol; 2018 Oct; 40(10):1010428318808670. PubMed ID: 30360692
[TBL] [Abstract][Full Text] [Related]
19. Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy.
Yamamoto S; Egashira N
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477371
[TBL] [Abstract][Full Text] [Related]
20. Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy.
Moschetti G; Amodeo G; Maftei D; Lattanzi R; Procacci P; Sartori P; Balboni G; Onnis V; Conte V; Panerai A; Sacerdote P; Franchi S
J Neuroinflammation; 2019 Apr; 16(1):89. PubMed ID: 30995914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
